Benjamin Claass
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- T-cell and B-cell Immunology
- Hepatology top 10%
Papers in ⓘ
-
- Immune Cell Function and Interaction 2
- Galectins and Cancer Biology 1
-
- Epigenetics and DNA Methylation 1
- Bone Metabolism and Diseases 1
- TGF-β signaling in diseases 1
- Co-authors
- Emma M. Creagh (1 shared paper)Darren Ruane (1 shared paper)Derek T. O’Hagan (1 shared paper)Ed C. Lavelle (1 shared paper)Fiona A. Sharp (1 shared paper)Virginie Pétrilli (1 shared paper)Luke O'neill (1 shared paper)James Harris (1 shared paper)
- Journals
- The Journal of Immunology (2 papers)Journal of Leukocyte Biology (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Bone and Mineral Research (1 paper)
- Partner nations
- GermanyAustraliaSwitzerland
In The Last Decade
Benjamin Claass
5 papers receiving 644 citations
Peers
Comparison fields: 5 of 83
- Immunology 401
- Hepatology 57
- Pharmaceutical Science 41
- Molecular Biology 291
- Microbiology 26
Countries citing papers authored by Benjamin Claass
This map shows the geographic impact of Benjamin Claass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Claass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Claass more than expected).
Fields of papers citing papers by Benjamin Claass
This network shows the impact of papers produced by Benjamin Claass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Claass. The network helps show where Benjamin Claass may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Claass, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 437 | |
| 2 | 2011 | 71 | |
| 3 | 2013 | 54 | |
| 4 | 2013 | 47 | |
| 5 | 2014 | 41 |
About Benjamin Claass
Benjamin Claass is a scholar working on Immunology, Molecular Biology, Hepatology, Oncology and Infectious Diseases, having authored 5 papers that have together received 650 indexed citations. Recurring topics across this work include Liver physiology and pathology (3 papers), Liver Diseases and Immunity (2 papers), Immune Cell Function and Interaction (2 papers), Epigenetics and DNA Methylation (1 paper), Bone health and treatments (1 paper), Galectins and Cancer Biology (1 paper), Bone Metabolism and Diseases (1 paper) and TGF-β signaling in diseases (1 paper). The work is most often cited by research in Immunology (401 citations), Hepatology (57 citations), Pharmaceutical Science (41 citations), Molecular Biology (291 citations) and Microbiology (26 citations). Benjamin Claass has collaborated with scholars based in Germany, Australia and Switzerland. Frequent co-authors include Emma M. Creagh, Darren Ruane, Derek T. O’Hagan, Ed C. Lavelle, Fiona A. Sharp, Virginie Pétrilli, Luke O'neill, James Harris, Padma Malyala and Jürg Tschopp. Their work appears in journals such as The Journal of Immunology, Journal of Leukocyte Biology, Proceedings of the National Academy of Sciences and Journal of Bone and Mineral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.